New Developments in China’s Drug Change Management Regulations
Arnold Porter
AUGUST 20, 2021
The Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) recently released the Acceptance Review Guideline on Biological Products Changes (for Trial Implementation). Latest Developments in China’s Drug Change Management Regulations. ???????????????. “????”???????????????????????????????????????2019?????????????20???????????????????????????????????????????????????????????.
Let's personalize your content